One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas

被引:40
作者
Croner, Roland S. [1 ]
Schellerer, Vera [1 ]
Demund, Helene [1 ]
Schildberg, Claus [1 ]
Papadopulos, Thomas [2 ]
Naschberger, Elisabeth [3 ]
Stuerzl, Michael [3 ]
Matzel, Klaus E. [1 ]
Hohenberger, Werner [1 ]
Schlabrakowski, Anne [4 ]
机构
[1] Univ Erlangen Nurnberg, Dept Surg, D-8520 Erlangen, Germany
[2] Vivantes Humboldt Clin, Dept Pathol, Berlin, Germany
[3] Univ Erlangen Nurnberg, Dept Mol & Expt Med, D-8520 Erlangen, Germany
[4] Univ Erlangen Nurnberg, Dept Pathol, D-8520 Erlangen, Germany
关键词
DISSEMINATED TUMOR-CELLS; CLINICAL-SIGNIFICANCE; INTRAOPERATIVE DETECTION; MINIMUM NUMBER; BREAST-CANCER; METASTASES; RESECTION; MICROMETASTASIS; SPECIMENS; COLON;
D O I
10.1186/1479-5876-8-83
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Accurate histopathological evaluation of resected lymph nodes (LN) is essential for the reliable staging of colorectal carcinomas (CRC). With conventional sectioning and staining techniques usually only parts of the LN are examined which might lead to incorrect tumor staging. A molecular method called OSNA (One Step Nucleic Acid Amplification) may be suitable to determine the metastatic status of the complete LN and therefore improve staging. Methods: OSNA is based on a short homogenisation step and subsequent automated amplification of cytokeratin 19 (CK19) mRNA directly from the sample lysate, with result available in 30-40 minutes. In this study 184 frozen LN from 184 patients with CRC were investigated by both OSNA and histology (Haematoxylin & Eosin staining and CK19 immunohistochemistry), with half of the LN used for each method. Samples with discordant results were further analysed by RT-PCR for CK19 and carcinoembryonic antigen (CEA). Results: The concordance rate between histology and OSNA was 95.7%. Three LN were histology+/OSNA- and 5 LN histology-/OSNA+. RT-PCR supported the OSNA result in 3 discordant cases, suggesting that metastases were exclusively located in either the tissue analysed by OSNA or the tissue used for histology. If these samples were excluded the concordance was 97.2%, the sensitivity 94.9%, and the specificity 97.9%. Three patients (3%) staged as UICC I or II by routine histopathology were upstaged as LN positive by OSNA. One of these patients developed distant metastases (DMS) during follow up. Conclusion: OSNA is a new and reliable method for molecular staging of lymphatic metastases in CRC and enables the examination of whole LN. It can be applied as a rapid diagnostic tool to estimate tumour involvement in LN during the staging of CRC.
引用
收藏
页数:6
相关论文
共 27 条
[1]  
Berberoglu U, 2004, HEPATO-GASTROENTEROL, V51, P1689
[2]   The use of molecular profiling of early colorectal cancer to predict micrometastases [J].
Bilchik, AJ ;
Nora, DT ;
Saha, S ;
Turner, R ;
Wiese, D ;
Kuo, C ;
Ye, X ;
Morton, DL ;
Hoon, DSB .
ARCHIVES OF SURGERY, 2002, 137 (12) :1377-1383
[3]   Lymph node recovery from colorectal tumor specimens: Recommendation for a minimum number of lymph nodes to be examined [J].
Cianchi, F ;
Palomba, A ;
Boddi, V ;
Messerini, L ;
Pucciani, F ;
Perigli, G ;
Bechi, P ;
Cortesini, C .
WORLD JOURNAL OF SURGERY, 2002, 26 (03) :384-389
[4]   The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer [J].
Davies, Mark ;
Arumugam, Ponnandai J. ;
Shah, Varsha I. ;
Watkins, Alun ;
Morgan, Andrew Roger ;
Carr, Nicholas D. ;
Beynon, John .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (03) :175-179
[5]   Estimates of the cancer incidence and mortality in Europe in 2006 [J].
Ferlay, J. ;
Autier, P. ;
Boniol, M. ;
Heanue, M. ;
Colombet, M. ;
Boyle, P. .
ANNALS OF ONCOLOGY, 2007, 18 (03) :581-592
[6]   Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years - Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities [J].
Goldstein, NS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (02) :179-189
[7]   The TNM system: Our language for cancer care [J].
Greene, FL ;
Sobin, LH .
JOURNAL OF SURGICAL ONCOLOGY, 2002, 80 (03) :119-120
[8]   Prognostic factor research in oncology [J].
Hermanek, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (04) :371-374
[9]  
Hermanek P, 2000, Surg Oncol Clin N Am, V9, P33
[10]   Lymphadenectomy with tumors of the lower gastrointestinal tract [J].
Hohenberger W. ;
Merkel S. ;
Weber K. .
Der Chirurg, 2007, 78 (3) :217-225